{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:59:35Z","timestamp":1778857175046,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":4201,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1017\/s1041610212002037","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T11:23:15Z","timestamp":1354274595000},"page":"1199-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Tomoyuki","family":"Nagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610212002037_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S1092852900017284","article-title":"Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms","volume":"13","author":"F\u00e9nelon","year":"2008","journal-title":"CNS Spectrums"},{"key":"10.1017\/S1041610212002037_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","article-title":"Auditory hallucinations in Parkinson's disease","volume":"64","author":"Inzelberg","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1017\/S1041610212002037_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pnpbp.2006.06.016","article-title":"Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease","volume":"31","author":"Meco","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1017\/S1041610212002037_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2007-979504","article-title":"Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine","volume":"30","author":"Normann","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1017\/S1041610212002037_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1017\/S1041610210000554","article-title":"New onset multimodal hallucinations associated with mirtazapine: a case report","volume":"22","author":"Padala","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610212002037_bb0035","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group","volume":"22","author":"Ravina","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1017\/S1041610212002037_bb0040","doi-asserted-by":"crossref","unstructured":"Seitz D. P. , AdunuriN., GillS. S., GruneirA., HerrmannN. and RochonP. (2011) Antidepressants for agitation and psychosis in dementia. Cochrane Database of Systematic Reviews.","DOI":"10.1002\/14651858.CD008191.pub2"},{"key":"10.1017\/S1041610212002037_bb0045","doi-asserted-by":"crossref","unstructured":"Tagai K. , NagataT., ShinagawaS., TsunoN., OzoneM. and NakayamaK. (in press). Mirtazapine improves visual hallucinations in Parkinson's disease: a case report. Psychogeriatrics, 1\u20135, doi:10.1111\/j.1479-8301.2012.00432.x.","DOI":"10.1111\/j.1479-8301.2012.00432.x"},{"key":"10.1017\/S1041610212002037_bb0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00002512-200825080-00004","article-title":"Pathophysiology and treatment of psychosis in Parkinson's disease: a review","volume":"25","author":"Zahodne","year":"2008","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610212002037_bb0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224013802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224013802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610212002037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T03:35:20Z","timestamp":1736393720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224013802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1041610224013802"],"URL":"https:\/\/doi.org\/10.1017\/s1041610212002037","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610212002037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Copyright \u00a9 International Psychogeriatric Association 2012. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}